TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks.
Nat Commun
; 14(1): 1810, 2023 03 31.
Article
in En
| MEDLINE
| ID: mdl-37002234
Full text:
1
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Poly(ADP-ribose) Polymerase Inhibitors
Type of study:
Prognostic_studies
Limits:
Humans
/
Male
Language:
En
Year:
2023
Type:
Article